New York State Common Retirement Fund
KYMR icon

New York State Common Retirement Fund’s Kymera Therapeutics KYMR Stock Holding History

New York State Common Retirement Fund’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
28,780
+6,911
+32% +$594K ﹤0.01% 1252
2026
Q1 		$1.82M Sell
21,869
-3,727
-15% -$295K ﹤0.01% 1421
2025
Q4 		$1.99M Buy
25,596
+1,200
+5% +$81K ﹤0.01% 1407
2025
Q3 		$1.38M Buy
24,396
+9,847
+68% +$444K ﹤0.01% 1571
2025
Q2 		$635K Hold
14,549
– – ﹤0.01% 1829
2025
Q1 		$398K Hold
14,549
– – ﹤0.01% 1962
2024
Q4 		$585K Sell
14,549
-1,100
-7% -$49.7K ﹤0.01% 1887
2024
Q3 		$741K Sell
15,649
-5,200
-25% -$230K ﹤0.01% 1783
2024
Q2 		$622K Buy
20,849
+4,172
+25% +$144K ﹤0.01% 1960
2024
Q1 		$670K Buy
16,677
+57
+0.3% +$2.04K ﹤0.01% 1958
2023
Q4 		$423K Sell
16,620
-284
-2% -$5.08K ﹤0.01% 2157
2023
Q3 		$235K Buy
16,904
+148
+0.9% +$2.98K ﹤0.01% 2355
2023
Q2 		$385K Sell
16,756
-4,135
-20% -$118K ﹤0.01% 2207
2023
Q1 		$619K Sell
20,891
-6,147
-23% -$198K ﹤0.01% 2071
2022
Q4 		$675K Buy
27,038
+7
+0% +$187 ﹤0.01% 2168
2022
Q3 		$588K Buy
27,031
+78
+0.3% +$2.06K ﹤0.01% 2252
2022
Q2 		$531K Sell
26,953
-43
-0.2% -$1K ﹤0.01% 2335
2022
Q1 		$1.14M Buy
26,996
+2,503
+10% +$106K ﹤0.01% 2039
2021
Q4 		$1.55M Buy
24,493
+1,857
+8% +$108K ﹤0.01% 1901
2021
Q3 		$1.33M Sell
22,636
-2,241
-9% -$130K ﹤0.01% 1985
2021
Q2 		$1.21M Buy
24,877
+15,277
+159% +$663K ﹤0.01% 2138
2021
Q1 		$373K Buy
9,600
+1,700
+22% +$102K ﹤0.01% 2578
2020
Q4 		$490K Buy
+7,900
New +$385K ﹤0.01% 2367

Other funds holding KYMR

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

New York State Common Retirement Fund's KYMR Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Kymera Therapeutics (KYMR) stake by 32% in Q2 2026, buying an estimated $594K and bringing the position to 28,780 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

New York State Common Retirement Fund first reported a position in KYMR in Q4 2020 and has held it in 23 quarters since. 64 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • New York State Common Retirement Fund held 28,780 shares of Kymera Therapeutics worth $3.3M as of Q2 2026.
  • New York State Common Retirement Fund bought 6,911 Kymera Therapeutics shares in Q2 2026, an estimated $594K.
  • Kymera Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1252 holding.
  • New York State Common Retirement Fund first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 64 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.